A new study published in Frontiers of Engineering Management presents a comprehensive evaluation system to assess innovation ...

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced ...

Exploratory Phase 2 analysis shows Verrica’s novel oncolytic peptide, VP-315, reprograms the tumor microenvironment, ...

Using sophisticated RNA sequencing technology, biomedical researchers can measure the activity of our genes across millions of single cells, creating detailed maps of tissues, organs, and diseases.

When Google Research unveils something with the prefix “DS,” you know it’s about data. But DS-STAR, short for Data Science State-of-the-Art Reasoning agent, is more than just another AI experiment. It ...

Single-cell sequencing provides great insights into the inner workings of cells – but making sense of the data requires ...

In analyzing dozens of AI PoCs that sailed on through to full production use — or didn’t — six common pitfalls emerge.

Using sophisticated RNA sequencing technology, biomedical researchers can measure the activity of our genes across millions ...

VENTURE Study Exploratory Analysis Shows VK2735 Improved Cardiometabolic Parameters After 13 Weeks; Reducing Prediabetes and Metabolic Syndrome SAN DIEGO, Nov. 6, 2025 /PRNewswire/ -- Viking ...

Two weeks before the U.S. Federal Reserve's last meeting, with the federal government's data spigot closed, Atlanta Fed staff ...

Understanding the properties of different materials is an important step in material design. X-ray absorption spectroscopy ...